NIX

LOE Approaching

permethrin

NDATOPICALLOTIONPriority Review
Approved
Mar 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT06526377Phase 2Not Yet Recruiting

Natrunix in HLA-B27 Positive Subjects With Axial Spondyloarthritis

Started Aug 2026
60 enrolled
Axial Spondyloarthritis
NCT06590090Phase 2Not Yet Recruiting

Natrunix in Combination With Methotrexate for Rheumatoid Arthritis Treatment

Started Jul 2026
108 enrolled
Rheumatoid Arthritis
NCT07416058Phase 2Not Yet Recruiting

PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC

Started Jan 2026
61 enrolled
Lung Adenocarcinoma
NCT07209943N/ANot Yet Recruiting

Augmented Reality BCI Longitudinal Study for Persons With ALS, Stroke, TBI and SCI Utilizing Cognixion + Apple Vision Pro

Started Oct 2025
10 enrolled
ALS (Amyotrophic Lateral Sclerosis)TBI Traumatic Brain InjurySCI - Spinal Cord Injury+1 more
NCT07359092N/ACompleted

Spexin and Phoenixin-20 in Girls With Central Precocious Puberty

Started Dec 2024